Market Overview:
The global atorvastatin calcium market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, and growing demand for generics. By type, the chemical synthesis segment is expected to account for a major share of the global atorvastatin calcium market in 2018. However, biocatalysis is projected to be the fastest-growing segment during the forecast period. By application, tablet (including dispersible tablet and general tablet) is estimated to account for a majority share of the global atorvastatin calcium market in 2018; however, capsule is projected to be the fastest-growing application segment duringthe forecast period.
Product Definition:
Atorvastatin calcium is a lipid-lowering agent used to treat high cholesterol and triglyceride levels. It works by reducing the amount of cholesterol made by the liver. Atorvastatin calcium is important because it helps to lower bad cholesterol levels and can help reduce your risk of heart attack or stroke.
Chemical Synthesis:
Chemical synthesis is a procedure where numerous chemical substances are manufactured by bringing together various chemicals in a precise order. Chemical Synthesis includes reactions as well as processes like combination, separation, and recombination of chemicals. The process can be used for the production of diverse organic compounds such as alkaloids, aromatics, alcohols; however it is most commonly employed to produce petrochemicals and pharmaceutical drugs.
Biocatalysis:
Biocatalysis is a chemical process that involves the use of enzymes to accelerate and control reactions. Biocatalysts are used in biotransformation processes, thus enabling production of pharmaceuticals and fine chemicals.
Application Insights:
Based on application, the global atorvastatin calcium market is segmented into tablet, capsule and others. Tablet was estimated as the largest segment in 2017 and is also expected to be fastest growing over the forecast period owing to its convenience of use. Increasing awareness about cholesterol reduction among individuals aged 40 years and above has resulted in a higher demand for statins tablets. In addition, increasing R&D activities for developing new forms of atorvastatin calcium that are more effective than currently available products are anticipated to boost product demand over the forecast period.
The capsule form of this drug is projected to witness significant growth during the study period owing to its ease in administration coupled with reduced pill burden compared with conventional tablets or oral suspension drugs.
Regional Analysis:
North America dominated the global market in terms of revenue in 2017. The region is expected to maintain its dominance over the forecast period as well owing to factors such as developed healthcare infrastructure, high disposable income, and favorable reimbursement policies. Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population and increasing cardiovascular diseases (CVDs). Moreover, growing awareness regarding atorvastatin calcium tablets among patients is also likely to support regional growth.
Moreover, major manufacturers are expanding their manufacturing facilities in countries such as China and India owing to low production costs coupled with easy availability of raw materials required for drug production. For instance, Pfizer Inc., one of the leading pharmaceutical companies has announced plans for constructing a new manufacturing plant in India which will be operational by 2019.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) due to changing lifestyle and dietary habits.
- Growing geriatric population susceptible to CVDs.
- Rising awareness about the benefits of statins in preventing CVDs.
- Availability of generic atorvastatin calcium products at affordable prices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Atorvastatin Calcium Market Research Report
By Type
Chemical Synthesis, Biocatalysis, Others
By Application
Tablet (Including Dispersible Tablet and General Tablet), Capsule, Others
By Companies
Pfizer, DSM Sinochem Pharmaceuticals, Cadila Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy’s, Morepen, Teva Pharmaceutical Industries, Apotex Pharmachem, Sandoz Inc, Mylan Pharmaceuticals Inc., Kremers Urban Pharmaceuticals Inc., ScieGen Pharmaceuticals, Inc., Zheijang Neo-Dankon Pharmaceutical, Ningbo Menovo Pharmaceuticals Group, Jialin Pharmaceutical, Topfond, Zhejiang Hisun Pharmacutical, Zhejiang Hongyuan Pharmaceutical, Hubei Yitai Pharmaceutical, Jiangsu Hengrui Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Atorvastatin Calcium Market Report Segments:
The global Atorvastatin Calcium market is segmented on the basis of:
Types
Chemical Synthesis, Biocatalysis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet (Including Dispersible Tablet and General Tablet), Capsule, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- DSM Sinochem Pharmaceuticals
- Cadila Pharmaceuticals
- Sun Pharmaceutical Industries
- Dr. Reddy’s
- Morepen
- Teva Pharmaceutical Industries
- Apotex Pharmachem
- Sandoz Inc
- Mylan Pharmaceuticals Inc.
- Kremers Urban Pharmaceuticals Inc.
- ScieGen Pharmaceuticals, Inc.
- Zheijang Neo-Dankon Pharmaceutical
- Ningbo Menovo Pharmaceuticals Group
- Jialin Pharmaceutical
- Topfond
- Zhejiang Hisun Pharmacutical
- Zhejiang Hongyuan Pharmaceutical
- Hubei Yitai Pharmaceutical
- Jiangsu Hengrui Medicine
Highlights of The Atorvastatin Calcium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemical Synthesis
- Biocatalysis
- Others
- By Application:
- Tablet (Including Dispersible Tablet and General Tablet)
- Capsule
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Atorvastatin Calcium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Atorvastatin calcium is a medication used to lower blood cholesterol. It is also known as Lipitor.
Some of the key players operating in the atorvastatin calcium market are Pfizer, DSM Sinochem Pharmaceuticals, Cadila Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy¢â‚¬â„¢s, Morepen, Teva Pharmaceutical Industries, Apotex Pharmachem, Sandoz Inc, Mylan Pharmaceuticals Inc., Kremers Urban Pharmaceuticals Inc., ScieGen Pharmaceuticals, Inc., Zheijang Neo-Dankon Pharmaceutical, Ningbo Menovo Pharmaceuticals Group, Jialin Pharmaceutical, Topfond, Zhejiang Hisun Pharmacutical, Zhejiang Hongyuan Pharmaceutical, Hubei Yitai Pharmaceutical, Jiangsu Hengrui Medicine.
The atorvastatin calcium market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Atorvastatin Calcium Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Atorvastatin Calcium Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Atorvastatin Calcium Market - Supply Chain
4.5. Global Atorvastatin Calcium Market Forecast
4.5.1. Atorvastatin Calcium Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Atorvastatin Calcium Market Size (000 Units) and Y-o-Y Growth
4.5.3. Atorvastatin Calcium Market Absolute $ Opportunity
5. Global Atorvastatin Calcium Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Atorvastatin Calcium Market Size and Volume Forecast by Type
5.3.1. Chemical Synthesis
5.3.2. Biocatalysis
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Atorvastatin Calcium Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Atorvastatin Calcium Market Size and Volume Forecast by Application
6.3.1. Tablet (Including Dispersible Tablet and General Tablet)
6.3.2. Capsule
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Atorvastatin Calcium Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Atorvastatin Calcium Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Atorvastatin Calcium Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Atorvastatin Calcium Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Atorvastatin Calcium Demand Share Forecast, 2019-2026
9. North America Atorvastatin Calcium Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Atorvastatin Calcium Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Atorvastatin Calcium Market Size and Volume Forecast by Application
9.4.1. Tablet (Including Dispersible Tablet and General Tablet)
9.4.2. Capsule
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Atorvastatin Calcium Market Size and Volume Forecast by Type
9.7.1. Chemical Synthesis
9.7.2. Biocatalysis
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Atorvastatin Calcium Demand Share Forecast, 2019-2026
10. Latin America Atorvastatin Calcium Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Atorvastatin Calcium Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Atorvastatin Calcium Market Size and Volume Forecast by Application
10.4.1. Tablet (Including Dispersible Tablet and General Tablet)
10.4.2. Capsule
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Atorvastatin Calcium Market Size and Volume Forecast by Type
10.7.1. Chemical Synthesis
10.7.2. Biocatalysis
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Atorvastatin Calcium Demand Share Forecast, 2019-2026
11. Europe Atorvastatin Calcium Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Atorvastatin Calcium Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Atorvastatin Calcium Market Size and Volume Forecast by Application
11.4.1. Tablet (Including Dispersible Tablet and General Tablet)
11.4.2. Capsule
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Atorvastatin Calcium Market Size and Volume Forecast by Type
11.7.1. Chemical Synthesis
11.7.2. Biocatalysis
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Atorvastatin Calcium Demand Share, 2019-2026
12. Asia Pacific Atorvastatin Calcium Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Atorvastatin Calcium Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Atorvastatin Calcium Market Size and Volume Forecast by Application
12.4.1. Tablet (Including Dispersible Tablet and General Tablet)
12.4.2. Capsule
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Atorvastatin Calcium Market Size and Volume Forecast by Type
12.7.1. Chemical Synthesis
12.7.2. Biocatalysis
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Atorvastatin Calcium Demand Share, 2019-2026
13. Middle East & Africa Atorvastatin Calcium Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Atorvastatin Calcium Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Atorvastatin Calcium Market Size and Volume Forecast by Application
13.4.1. Tablet (Including Dispersible Tablet and General Tablet)
13.4.2. Capsule
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Atorvastatin Calcium Market Size and Volume Forecast by Type
13.7.1. Chemical Synthesis
13.7.2. Biocatalysis
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Atorvastatin Calcium Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Atorvastatin Calcium Market: Market Share Analysis
14.2. Atorvastatin Calcium Distributors and Customers
14.3. Atorvastatin Calcium Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DSM Sinochem Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cadila Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sun Pharmaceutical Industries
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Dr. Reddys
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Morepen
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Apotex Pharmachem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sandoz Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mylan Pharmaceuticals Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Kremers Urban Pharmaceuticals Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. ScieGen Pharmaceuticals, Inc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zheijang Neo-Dankon Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Ningbo Menovo Pharmaceuticals Group
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Jialin Pharmaceutical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Topfond
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Zhejiang Hisun Pharmacutical
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Zhejiang Hongyuan Pharmaceutical
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Hubei Yitai Pharmaceutical
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Jiangsu Hengrui Medicine
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
